Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments

By Espinosa A.M.   Sierra A.Y.   Barrero C.A.   Cepeda L.A.   Cantor E.M.   Lombo T.B.   Guzman F.   Avila S.J.   Patarroyo M.A.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1033-1043

Elsevier

Access to resources Recommend Favorite

Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens

By Rogers W.O.   Gowda K.   Hoffman S.L.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 3136-3144

Elsevier

Access to resources Recommend Favorite

The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3-1cp45, is attenuated, immunogenic, and protective in African green monkeys

By Skiadopoulos M.H.   Tatem J.M.   Surman S.R.   Mitcho Y.   Wu S.-L.   Elkins W.R.   Murphy B.R.  

Vaccine, Vol. 20, Iss. 13, 2002-03 ,pp. : 1846-1852

Elsevier

Access to resources Recommend Favorite

Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1 19 ) and T helper epitopes of tetanus toxoid

By Keitel W.A.   Kester K.E.   Atmar R.L.   White A.C.   Bond N.H.   Holland C.A.   Krzych U.   Palmer D.R.   Egan A.   Diggs C.   Ballou W.R.   Hall B.F.   Kaslow D.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 531-539

Elsevier

Access to resources Recommend Favorite

Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes

By Rodrguez L.E.   Urquiza M.   Ocampo M.   Curtidor H.   Suarez J.   Garca J.   Vera R.   Puentes A.   Lopez R.   Pinto M.   Rivera Z.   Patarroyo M.E.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1331-1339

Elsevier

Access to resources Recommend Favorite